MedCap AB (publ) (FRA:61MA)

Market Cap	706.25M +40.5%
Revenue (ttm)	194.93M +16.7%
Net Income	20.31M +6.0%
EPS	1.36 +4.8%
Shares Out	n/a
PE Ratio	34.77
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	3
Open	45.32
Previous Close	46.54
Day's Range	45.32 - 45.32
52-Week Range	35.65 - 59.60
Beta	n/a
RSI	57.90
Earnings Date	Apr 29, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orth...

• Industry: Investors, not elsewhere classified
• Founded: 2001
• Employees: 637
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 61MA

Financial Performance

In 2025, MedCap AB's revenue was 2.11 billion, an increase of 16.73% compared to the previous year's 1.81 billion. Earnings were 219.80 million, an increase of 5.98%.

Financial numbers in SEK